Pharmacologic activation of the human coronary microcirculation in vitro: Endothelium-dependent dilation and differential responses to acetylcholine

Cardiovascular Research

Volumn 38, Issue 3, 1998, Pages 744-750

  Miller Jr , Francis J ^a   Dellsperger, Kevin C ^a   Gutterman, David D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Acetylcholine; Adenosine diphosphate; Atria; Coronary circulation; Human; Microcirculation; Nitric oxide; Ventricle

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BRADYKININ; CALCIMYCIN; ENDOTHELIN 1; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE; SUBSTANCE P;

ADOLESCENT; ADULT; AGE; AGED; ARTERIOLE; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART LEFT VENTRICLE; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; INFANT; MALE; MICROCIRCULATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARACHIDONIC ACID; BRADYKININ; CALCIMYCIN; CHILD; CHILD, PRESCHOOL; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HEART ATRIA; HEART VENTRICLES; HUMANS; INFANT; INFANT, NEWBORN; IONOPHORES; MALE; MICROCIRCULATION; MIDDLE AGED; STIMULATION, CHEMICAL; SUBSTANCE P; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0032103815     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00035-2     Document Type: Article

References (24)

1. [1] Rubanyi GM. Endothelium-derived relaxing and contracting factor. J Cell Biochem 1991;46:27-36.
2. [2] Marshall JJ, Kontos HA. Endothelium-derived relaxing factors: a perspective from in vivo data. Hypertension 1990;16:371-386.
3. [3] Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in edrf/nitric oxide activity. Circulation 1992;85:1927-1938.
4. [4] El-Tamimi H, Mansour M, Wargovich J, et al. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery inpatients with coronary artery disease. Circulation 1994;89:45-51.
5. [5] Harrison DG, Freiman PC, Armstrong ML, Marcus ML, Heistad DD. Alterations of vascular reactivity in atherosclerosis. Circ Res 1987;61:II74-II80.
6. [6] Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;87(suppl. V):V67-V76.
7. [7] Williamson JR, Kilo C, Tilton RG, Mechanisms of glucose-and diabetes-induced vascular dysfunction. In: Ruderman N, Williamson J, Brownlee M, editors. Hyperglycemia, diabetes and vascular disease. New York: Oxford University Press, 1992;107-132.
8. [8] Antony I, Lerebours G, Nitenberg A. Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation 1995;91:1624-1628.
9. [9] Brush JE Jr., Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19:809-815.
10. [10] Gilligan DM, Guetta V, Panza JA, et al. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994;90:35-41.
11. [11] Marcus ML, The coronary circulation in health and disease, New York: McGraw Hill, 1983.
12. [12] Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986;251:H779-H788.
13. [13] Myers PR, Banitt PF, Guerra RJ, Harrison DG. Characteristics of canine coronary resistance arteries: importance of endothelium. Am J Physiol 1989;257:H603-H610.
14. [14] Myers PR, Banitt PF, Guerra RJ, Harrison DG. Role of the endothelium in modulation of the acetylcholine vasoconstrictor response in porcine coronary microvessels. Cardiovasc Res 1991;25:129-137.
15. [15] Miller FJ Jr., Dellsperger KC, Gutterman DD. Myogenic constriction of human coronary arterioles. Am J Physiol 1997;273:H257-H264.
16. [16] Kuo L, Chilian WM, Davis MJ. Coronary arteriolar myogenic response is independent of endothelium. Circ Res 1990;66:860-866.
17. [17] Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 1990;81:482-490.
18. [18] Shiode N, Nakayama K, Morishima N, et al. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients. Am Heart J 1996;131:1051-1057.
19. [19] Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-1474.
20. [20] Toda N, Okamura T. Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries. Am J Physiol 1989;257:H988-H995.
21. [21] Pilay CV, Reid JVO. Histochemical localization of acetylcholinesterase in the wall of cardiac blood vessels in the baboon, dog, and vervet monkey. Basic Res Cardiol 1982;77:213-219.
22. [22] Angus JA, Cocks TM, McPherson GA, Broughton A. The acetylcholine paradox: a constrictor of human small coronary arteries even in the presence of endothelium. Clin Exp Pharmacol Physiol 1991;18:33-36.
23. [23] Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 1994;113:1548-1553.
24. [24] Du XY, Schoemaker RG, Bos E, Saxena PR. Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur J Pharmacol 1994;259:173-180.